Brain Cancer

According to the American Cancer Society, the chance a person will develop a malignant tumor of the brain or spinal cord in his or her lifetime is less than 1%.

Survival rates for brain and spinal cord cancers vary, depending on the type of tumor. 

GoPath has developed several molecular tests to diagnose brain cancer and to detect genetic mutations that are associated with brain cancer. This means that our tests yield results that help your doctor create a treatment plan that's tailor-made to best treat your particular type of cancer. 

These tests include:

          •     Brain Profile - Analyzes genes associated with brain cancer prognosis 
          •     OncoTargetTM - Detects genetic mutations in a tumor to monitor treatment resistance
          •     Brain Biopsy